Aldesleukin With or Without Vaccine Therapy in Treating Patients With Stage IV Melanoma
Clinical trial NCT00726739 · COMPLETED
Trial details
- NCT number
- NCT00726739
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2011-06-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.